Komrokji, Z., Ali, N. A., Xie, Z., Chan, O., Kuykendall, A., Yun, S., Shallis, R., Reynolds, S., Sweet, K., Walker, A., Lancet, J., Padron, E., Sallman, D., Komrokji, R. (2025). Elevated serum erythropoietin level is associated with unique clinical and genomic features, response to treatment, and outcomes in lower-risk myelodysplastic syndromes. Blood. https://doi.org/10.1182/blood-2025-3856